India’s IPA Sees No Imminent Coronavirus Shortages
Welcomes Initiatives To Promote Domestic Manufacturing Of APIs And KSMs
The Indian Pharmaceutical Alliance is working closely with the World Health Organization and International Generic and Biosimilar Medicines Association, as well as regional off-patent industry bodies in the US and Europe, to “navigate challenges on the manufacturing and logistics front” due to the coronavirus pandemic. Meanwhile, the IPA has welcomed domestic initiatives to boost API manufacturing.
